Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis

被引:8
|
作者
Ajithkumar, Priyadarshana [1 ]
Vasantharajan, Sai Shyam [1 ]
Pattison, Sharon [2 ]
McCall, John L. [3 ]
Rodger, Euan J. [1 ]
Chatterjee, Aniruddha [1 ,4 ]
机构
[1] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9016, New Zealand
[2] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin 9016, New Zealand
[3] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Dunedin 9016, New Zealand
[4] UPES Univ, Sch Hlth Sci & Technol, Dehra Dun 248007, India
关键词
colorectal cancer; DNA methylation; epigenetics; metastasis; lymph node; liver; histone modification; biomarkers; LYMPH-NODE METASTASIS; PROMOTER HYPERMETHYLATION; LYMPHOVASCULAR INVASION; PROGNOSTIC VALUE; POOR-PROGNOSIS; GENOME-WIDE; METHYLATION; EXPRESSION; PROLIFERATION; LANDSCAPE;
D O I
10.3390/ijms25020874
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastatic progression is a complex, multistep process and the leading cause of cancer mortality. There is growing evidence that emphasises the significance of epigenetic modification, specifically DNA methylation and histone modifications, in influencing colorectal (CRC) metastasis. Epigenetic modifications influence the expression of genes involved in various cellular processes, including the pathways associated with metastasis. These modifications could contribute to metastatic progression by enhancing oncogenes and silencing tumour suppressor genes. Moreover, specific epigenetic alterations enable cancer cells to acquire invasive and metastatic characteristics by altering cell adhesion, migration, and invasion-related pathways. Exploring the involvement of DNA methylation and histone modification is crucial for identifying biomarkers that impact cancer prediction for metastasis in CRC. This review provides a summary of the potential epigenetic biomarkers associated with metastasis in CRC, particularly DNA methylation and histone modifications, and examines the pathways associated with these biomarkers.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Epigenetic Biomarkers in Colorectal Cancer
    Mukesh Verma
    Vineet Kumar
    Molecular Diagnosis & Therapy, 2017, 21 : 153 - 165
  • [2] EPIGENETIC BIOMARKERS IN COLORECTAL CANCER
    Kolligs, F. T.
    TUMOR BIOLOGY, 2010, 31 : S24 - S24
  • [3] Epigenetic Biomarkers in Colorectal Cancer
    Verma, Mukesh
    Kumar, Vineet
    MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (02) : 153 - 165
  • [4] Genetic and Epigenetic Biomarkers of Colorectal Cancer
    Choong, Miew Keen
    Tsafnat, Guy
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (01) : 9 - 15
  • [5] Epigenetic biomarkers of chemoresistance in colorectal cancer
    Moutinho, Catia
    Martinez-Cardus, Anna
    Martinez-Balibrea, Eva
    Abad, Albert
    Esteller, Mane
    CANCER RESEARCH, 2012, 72
  • [6] Epigenetic biomarkers in colorectal cancer diagnostics
    Rawson, James B.
    Bapat, Bharati
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (05) : 499 - 509
  • [7] An epigenetic signature of advanced colorectal cancer metastasis
    Rodger, Euan J.
    Gimenez, Gregory
    Ajithkumar, Priyadarshana
    Stockwell, Peter A.
    Almomani, Suzan
    Bowden, Sarah A.
    Leichter, Anna L.
    Ahn, Antonio
    Pattison, Sharon
    McCall, John L.
    Schmeier, Sebastian
    Frizelle, Frank A.
    Eccles, Michael R.
    Purcell, Rachel V.
    Chatterjee, Aniruddha
    ISCIENCE, 2023, 26 (06)
  • [8] The role of epigenetic modifications in Colorectal Cancer Metastasis
    Su, Riya
    Wu, Xinlin
    Tao, Liang
    Wang, Changshan
    CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (04) : 521 - 539
  • [9] The role of epigenetic modifications in Colorectal Cancer Metastasis
    Riya Su
    Xinlin Wu
    Liang Tao
    Changshan Wang
    Clinical & Experimental Metastasis, 2022, 39 : 521 - 539
  • [10] Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration
    Oh, Chang Kyo
    Cho, Young-Seok
    INTESTINAL RESEARCH, 2024, 22 (02) : 131 - 151